The company hasn’t yet disclosed its share price or date for an initial public offering.
This group of young professionals was chosen from a pool of nearly 500 nominations.
Good job Arti Santhanam, John Gustin and Silvia Goncalves!
Calling all entrepreneurs and Innovators in the DMV area… Have you heard? JLABS @ Washington DC is coming to the District! In anticipation of our upcoming launch we are hosting a community mixer. This is a wonderful opportunity for those looking to expand your network, connect with other entrepreneurs, VCs, academics and industry leaders. You’ll get an chance to meet the local JLABS Team, learn about future programming and how to become a resident.
Here are seven pieces of wisdom and advice about the role of innovation in healthcare that executives from hospitals and health systems across the country shared with Becker’s Hospital Review in August:
Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for inebilizumab, an investigational anti-CD19 monoclonal antibody, for the treatment of patients with neuromyelitis optica spectrum disorder (NMOSD) — a rare autoimmune disease characterized by unpredictable attacks that often lead to severe, irreparable disability including blindness and paralysis.
Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced that it received a $3 million Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health to use its EchoMark & EchoSure devices to support arteriovenous (AV) fistula maturation and long-term viability. The award provides capital for prospective clinical studies and continued research and development efforts.
OCTOBER 8-10, 2019 | NATIONAL HARBOR, MD
DELIVERING INNOVATION ACCELERATING COMMERCIALIZATION
Join leadership from America’s seed fund, representing over $3.5B of early-state, high-risk technology funding for small business.
A University of Maryland (UMD) team has been awarded a $1 million grant by the National Science Foundation’s Integrative Strategies for Understanding Neural and Cognitive Systems (NCS) program to investigate the complex effects of intestinal serotonin on both gut and brain health. The project, “Developing engineering solutions to investigate microbiome-to-neuron communication,” aims to provide a more realistic picture of the complex gut-microbiome-brain axis system (GMBA).
These are the Baltimore Business Journal’s 2019 40 Under 40 honorees
This group of young professionals was chosen from a pool of nearly 500 nominations.